Skip to Content

CFZ 300 (Invokana 300 mg)

Generic Name: canagliflozin

Pill with imprint CFZ 300 is White, Capsule-shape and has been identified as Invokana 300 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Invokana is used in the treatment of diabetes, type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Invokana 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CFZ 300

Invokana

Generic Name:
canagliflozin
Imprint:
CFZ 300
Strength:
300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
SGLT-2 inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC):
50458-0141

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide